Nestlé Sells Vitamins Business for $1B to Focus on Growth

By ThePip DeskNestlé Sells Vitamins Business for $1B to Focus on Growth

Nestlé divests its vitamins, minerals, and supplements arm to Yellow Wood Partners for $1 billion, strategically refocusing on high-growth categories.

Nestlé has agreed to divest its mainstream vitamins, minerals, and supplements (VMS) business to Yellow Wood Partners in a $1 billion transaction. This strategic move underscores Nestlé’s commitment to reallocate resources towards categories promising higher growth within its extensive portfolio.

This divestment aligns with a broader corporate strategy to streamline operations. The company aims to concentrate on areas where it holds stronger competitive advantages, as stated by Nestlé CEO Philipp Navratil.

Key Transaction Figures

  • Deal Value: $1 billion for the VMS business.
  • Reported Sales (2025): The divested VMS business generated $1.2 billion in sales.
  • Previous Acquisition: Nestlé acquired core brands of The Bountiful Company for $5.75 billion four years prior.

The sale encompasses Nestlé’s “Holistic Health” portfolio, along with its US private-label supplements business. This includes a comprehensive set of associated manufacturing, packaging, warehousing, and distribution operations.

Divested Brands

  • Nature’s Bounty
  • Osteo Bi-Flex
  • Ester-C
  • Gard
  • Nuun
  • Puritan’s Pride
  • Sisu

This VMS business primarily operates in the United States, with an additional presence in markets such as Canada and China. The transaction awaits regulatory approvals and is projected to conclude in the first half of 2027.

Future Focus for Nestlé

Nestlé CEO Philipp Navratil confirmed that the sale allows the company to sharpen its focus. The food giant will continue to develop its premium, science-led VMS portfolio. This retained segment includes established brands like Solgar and Pure Encapsulations.

This divestiture marks a notable shift, occurring just four years after Nestlé acquired core brands, including Nature’s Bounty and Osteo Bi-Flex, for $5.75 billion. The current sale highlights a rapid strategic pivot to optimize its market position and resource allocation for future growth.

Home/business/Article